41 related articles for article (PubMed ID: 17451579)
1. Office-based facial plastics procedures: Neuromodulators.
Johnson AJ; Chen DS
World J Otorhinolaryngol Head Neck Surg; 2023 Sep; 9(3):220-226. PubMed ID: 37780669
[TBL] [Abstract][Full Text] [Related]
2. A Review of Complications Due to the Use of Botulinum Toxin A for Cosmetic Indications.
Sethi N; Singh S; DeBoulle K; Rahman E
Aesthetic Plast Surg; 2021 Jun; 45(3):1210-1220. PubMed ID: 33051718
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Lateral Periorbital Lines with Different Dilutions of IncobotulinumtoxinA.
Muti GF; Basso M
J Clin Aesthet Dermatol; 2017 Sep; 10(9):27-29. PubMed ID: 29344324
[No Abstract] [Full Text] [Related]
4. Botulinum Toxin in Aesthetic Medicine: Myths and Realities.
Dover JS; Monheit G; Greener M; Pickett A
Dermatol Surg; 2018 Feb; 44(2):249-260. PubMed ID: 29016535
[TBL] [Abstract][Full Text] [Related]
5. A Randomized, Comparative Study to Evaluate Efficacy and Safety of Two Injection Volumes of AbobotulinumtoxinA in Treatment of Glabellar Lines.
Punga AR; Alimohammadi M; Fagrell D; Nyberg F; Rees D; Wong C
Dermatol Surg; 2016 Aug; 42(8):967-76. PubMed ID: 27399956
[TBL] [Abstract][Full Text] [Related]
6. Neuromodulator threading: revisiting an approach to neurotoxin delivery.
Higgins HW; Lee KC; Enzer Y
J Clin Aesthet Dermatol; 2014 Jun; 7(6):38-41. PubMed ID: 25013538
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type A for the management of glabellar rhytids.
Tremaine AM; McCullough JL
Clin Cosmet Investig Dermatol; 2010 Apr; 3():15-23. PubMed ID: 21437056
[TBL] [Abstract][Full Text] [Related]
8. Cosmetic oculofacial applications of botulinum toxin: a report by the American Academy of Ophthalmology.
Kaltreider SA; Kennedy RH; Woog JJ; Bradley EA; Custer PL; Meyer DR; ;
Ophthalmology; 2005 Jun; 112(6):1159-67. PubMed ID: 15936443
[TBL] [Abstract][Full Text] [Related]
9. Understanding botulinum toxin. Surgical anatomy of the frown, forehead, and periocular region.
Wieder JM; Moy RL
Dermatol Surg; 1998 Nov; 24(11):1172-4. PubMed ID: 9834734
[TBL] [Abstract][Full Text] [Related]
10. A randomized, evaluator-blinded, two-center study of the safety and effect of volume on the diffusion and efficacy of botulinum toxin type A in the treatment of lateral orbital rhytides.
Carruthers A; Bogle M; Carruthers JD; Dover JS; Arndt KA; Hsu TS; Poirier J
Dermatol Surg; 2007 May; 33(5):567-71. PubMed ID: 17451579
[TBL] [Abstract][Full Text] [Related]
11. Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: does it matter?
Carruthers A; Carruthers J; Cohen J
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S97-104. PubMed ID: 17241422
[TBL] [Abstract][Full Text] [Related]
12. A pilot study on the effect of epinephrine on botulinum toxin treatment for periorbital rhytides.
Hantash BM; Gladstone HB
Dermatol Surg; 2007 Apr; 33(4):461-8. PubMed ID: 17430381
[TBL] [Abstract][Full Text] [Related]
13. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.
Sahai A; Dowson C; Khan MS; Dasgupta P
BJU Int; 2009 Jun; 103(11):1509-15. PubMed ID: 19389019
[TBL] [Abstract][Full Text] [Related]
14. Eyebrow height after botulinum toxin type A to the glabella.
Carruthers A; Carruthers J
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S26-31. PubMed ID: 17241411
[TBL] [Abstract][Full Text] [Related]
15. Management of the ageing eyebrow and forehead: an objective dose-response study with botulinum toxin.
Levy JL; Pons F; Jouve E
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):711-6. PubMed ID: 16836501
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
